Emergent BioSolutions under scrutiny following quality control issues with COVID-19 vaccines
SAUL LOEB/AFP via Getty Images (NEW YORK) -- For Emergent BioSolutions, Feb. 8 was a day to revel in their success -- at least as far as the public was concerned. Standing alongsid…
